Evolving Role of BTK Inhibitors in CLL: Sequencing, Combinations, and Novel Agents

Gain insights on the evolving role of BTK inhibitors for patients with CLL with an on-demand webcast downloadable slidesets and a podcast on frequently asked questions in CLL.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Supporters

This CE activity is supported through an educational grant from

AstraZeneca

BeiGene

Lilly